EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparative Study on Covalent and Noncovalent Endogenous Albumin-Binding β-Glucuronidase-Activated SN38 Prodrugs for Antitumor Efficacy

Yingxin Lu, Xing Jiang, Biyu Yang, Mengyuan Ding, Yanyan Shen, Jiyu Jin, Jiahui Yu iD, Wei Lu iD, Yi Chen, Shulei Zhu

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.4c03096 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Yingxin Lu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China No…. Hauptthemen laut MEDLINE: Prodrugs, Antineoplastic Agents, Glucuronidase, Irinotecan. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Rising-Star Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Albumin-binding prodrugs have been explored to overcome the limitations of small-molecule anticancer chemotherapy agents, such as inadequate physiological and pharmaceutical compatibility, as well as rapid renal clearance. Herein, we investigated two endogenous albumin-binding prodrugs, M-g-SN38 and S-g-SN38, forming macromolecular conjugates. Both prodrugs exhibited robust stability in murine and human plasma, crucial for their therapeutic potential. Selective activation by β-glucuronidase ensures minimal toxicity in their inactive state. Notably, M-g-SN38 exhibited higher cellular uptake, a longer circulation half-life, and enhanced tumor accumulation compared to S-g-SN38, suggesting its greater potential for improved antitumor efficacy. In vivo, M-g-SN38 exhibited significant antitumor activity, leading to profound tumor reduction and, in many cases, marked depletion and complete eradication in all treated mice in the HCT116 xenograft model. Furthermore, M-g-SN38 also demonstrated pronounced antitumor efficacy in the BxPC-3 xenograft model. Together, these findings provide new insights for the development of albumin-binding prodrugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsAntineoplastic AgentsGlucuronidaseIrinotecanAlbuminsAnimalsHumansMiceXenograft Model Antitumor AssaysCell Line, TumorMice, Nude

Substanzen

ProdrugsAntineoplastic AgentsGlucuronidaseIrinotecanAlbumins

Autor:innen und Institutionen

  • Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, PR China.
  • State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, PR China.
  • Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai 264117, PR China.
  • Innovation Center for AI and Drug Discovery, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, PR China.
  • ATLATL Innovation Center, 1077 Zhangheng Road, Shanghai 201203, PR China.

ORCID-Profile: Jiahui Yu, Wei Lu

Förderung

  • National Natural Science Foundation of China
  • Shanghai Rising-Star Program

Zitieren

APA

Lu, Y., Jiang, X., Yang, B., Ding, M., Shen, Y., Jin, J., Yu, J., Lu, W., Chen, Y., & Zhu, S. (2025). Comparative Study on Covalent and Noncovalent Endogenous Albumin-Binding β-Glucuronidase-Activated SN38 Prodrugs for Antitumor Efficacy. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c03096

Vancouver

Lu Y, Jiang X, Yang B, Ding M, Shen Y, Jin J, et al. Comparative Study on Covalent and Noncovalent Endogenous Albumin-Binding β-Glucuronidase-Activated SN38 Prodrugs for Antitumor Efficacy. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c03096

BibTeX
@article{Lu2025,
  author = {Lu, Yingxin and Jiang, Xing and Yang, Biyu and Ding, Mengyuan and Shen, Yanyan and Jin, Jiyu and Yu, Jiahui and Lu, Wei and Chen, Yi and Zhu, Shulei},
  title = {Comparative Study on Covalent and Noncovalent Endogenous Albumin-Binding β-Glucuronidase-Activated SN38 Prodrugs for Antitumor Efficacy},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.4c03096}
}
Kostenlos starten →